1. PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.
- Author
-
Tian, Wen, Guo, Hong-Sheng, Li, Chong-Yao, Cao, Wei, Wang, Xue-Ying, Mo, Dan, Hao, Xiao-Wei, Feng, Ying-Da, Sun, Yang, Lei, Fan, Zhang, Hui-Nan, Zhao, Ming-Gao, and Li, Xiao-Qiang
- Subjects
- *
ENDOTOXEMIA , *CARDIOMYOPATHIES , *CELLULAR signal transduction , *MESSENGER RNA , *LIPOPOLYSACCHARIDES - Abstract
Abstract Cardiac dysfunction is a vital complication during endotoxemia (ETM). Accumulating evidence suggests that enhanced glycolytic metabolism promotes inflammatory and myocardial diseases. In this study, we performed deep mRNA sequencing analysis on the hearts of control and lipopolysaccharide (LPS)-challenged mice (40 mg/kg, i.p.) and identified that the glycolytic enzyme, 6-phosphofructo-2-kinase (PFK-2)/fructose-2,6-bisphosphatase 3 (PFKFB3) might play an indispensable role in ETM-induced cardiac damage. Quantitative real-time PCR validated the transcriptional upregulation of PFKFB3 in the myocardium of LPS-challenged mice and immunoblotting and immunostaining assays confirmed that LPS stimulation markedly increased the expression of PFKFB3 at the protein level both in vivo and in vitro. The potent antagonist 3-(3pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) was used to block PFKFB3 activity in vivo (50 mg/kg, i.p.) and in vitro (10 μM). Echocardiographic analysis and TUNEL staining showed that 3PO significantly alleviated LPS-induced cardiac dysfunction and apoptotic injury in vivo. 3PO also suppressed the LPS-induced secretion of tumor necrosis factor-α, interleukin (IL)-1β, IL-6 and lactate in the serum, in addition to lactate in the myocardium. PFKFB3 inhibition also diminished the nuclear translocation and phosphorylation of transcription factor nuclear factor-κB (NF-κB) in both adult cardiomyocytes and HL-1 cells. Furthermore, immunoblotting analysis showed that 3PO inhibited LPS-induced apoptotic induction in cardiomyocytes. Taken together, these findings demonstrate that PFKFB3 participates in LPS-induced cardiac dysfunction via mediating inflammatory and apoptotic signaling pathway. Highlights • The mRNA-seq data showed a vital role of PFKFB3 in LPS-caused cardiac dysfunction. • LPS stimulated significant protein upregulation of PFKFB3 in cardiomyocytes. • PFKFB3 blocker alleviated LPS-induced cardiac dysfunction and myocardial injury. • PFKFB3 may promote cardiac dysfunction via mediating inflammation and apoptosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF